Transforming Perspectives on Immune System Diseases
There’s a noteworthy shift happening in how doctors perceive immune system diseases. Traditionally, treatments were primarily dictated by the diagnosis or the specific organ involved. But recent findings indicate that what might seem like unrelated health issues could actually stem from the same underlying immune pathway.
This discovery implies that a treatment designed for one ailment could also be beneficial for another. The vital question has evolved beyond merely identifying what illness a patient has; it now revolves around understanding which biological mechanisms are at play.
One significant factor driving this change has been the rise of precision biologic drugs that focus on particular immune pathways. Even though these treatments were originally tailored for specific conditions, physicians occasionally find that the same immune pathways are active in other disorders too.
This approach allows for the use of drugs in fresh contexts, targeting the mechanisms causing the diseases rather than just adhering to their diagnostic labels.
A poignant example of this is a cancer patient who suffered from persistent, intense itching even though his cancer was managed. This itchiness overshadowed his life – sleep became elusive, and daily functioning was a struggle. Despite trying antihistamines, steroids, and various traditional treatments, nothing worked.
Eventually, in a state of despair, he sought assisted death in Switzerland—not due to his cancer but because of the unbearable itching.
The ineffectiveness of standard treatments didn’t mean all hope was lost. In fact, it provided a crucial insight. Since antihistamines didn’t alleviate his issue, it was unlikely that histamine was the primary cause of his itch. Additionally, the failure of other typical therapies pointed towards the involvement of a different immune pathway.
As a result, doctors explored the possibility of cytokines linked to type 2 inflammation. These proteins play a role in immune cell communication and trigger inflammatory responses, and they’re also known to be significant in conditions like asthma and atopic dermatitis.
Using this knowledge, doctors decided to try a biologic therapy aimed at the same immune pathway, even though it wasn’t specifically created for itching related to cancer.
The outcome was impressive: after just three injections, his relentless itching subsided. In fact, during a follow-up appointment, he even destroyed his ticket to Switzerland.
This isn’t an isolated incident. As doctors recognized that other patients experiencing severe itching following cancer treatment could benefit similarly, clinical observations transitioned into structured research.
Still, it’s worth noting that not everyone reacts the same way, and the mechanisms behind these responses aren’t fully diagnosed yet. Yet, these experiences highlight the importance of pinpointing which immune pathway is driving a health condition.
Historically, immunology was viewed as a rather limited field focusing mainly on the immune system’s functioning. However, significant developments in understanding immune mechanisms and creating targeted therapies have broadened this perspective considerably in recent years.
The COVID-19 pandemic showcased how critically the immune system influences our health and daily lives. Yet, the transformation in this field began well before that.
With advancements in recognizing immune mechanisms, it became clear that they are instrumental across various organs and in multiple medical arenas.
To clarify a few terms, immunology covers the study of the immune system as a whole, addressing how it defends against infections and understanding the disruptions in its activity.
Allergies are just a segment within this wider field, reflecting abnormal immune responses to typically harmless substances, such as food or pollen.
Though the immune system excels at identifying and combating viruses and bacteria, its role extends beyond that. It also plays a part in inflammation, injury responses, healing, tumor detection, and maintaining balance between protection and harm.
Occasionally, however, it can overreact to a benign substance or not respond adequately to something harmful, leading to various issues including allergies and autoimmune diseases. So, allergy is merely a portion of a broader immunological landscape.
This complexity means that an immunologist’s work is more extensive than just addressing allergic diseases. It includes tackling immune deficiencies, autoimmune conditions, chronic inflammation, and cases where multiple symptoms of the same disease emerge in one patient.
In these scenarios, separate treatments for the skin, lungs, or digestive system might not suffice. It becomes essential for doctors to discern the shared immune mechanisms linking them.
Modern biologic therapies now allow doctors to specifically target a particular cell or pathway involved in a condition, rather than suppressing the immune system broadly. This is premised on the understanding that immune processes intersect with various diseases, and immunology is increasingly relevant across all branches of medicine, from oncology to dermatology.
The noticeable escalation of food allergy diagnoses among children is striking. However, not every suspected allergy is valid, and many childhood diagnoses may linger in a patient’s records for years without reevaluation.
Part of an allergist’s role is to determine whether an allergy has resolved or if it perhaps was incorrectly diagnosed from the beginning.
In some cases, a food challenge—slowly introducing a suspected allergen under medical supervision—can alleviate fears. Often, these tests yield relief, revealing that the child does not have an allergy. This revelation not only reopens dietary options but also alleviates ongoing anxiety for both the child and family.
Similarly, a penicillin allergy can remain on a medical record for long, even when it’s outdated or incorrect.
Numerous Israelis are labeled as penicillin-allergic, and sometimes this label arises from a reaction that wasn’t connected to the antibiotic at all.
For instance, a child given antibiotics during a viral infection might develop a rash due to the illness, not the medication. Unfortunately, unless reassessed, that child might carry the penicillin allergy label indefinitely.
Avoiding penicillin unnecessarily could restrict treatment options and force doctors to prescribe less suitable alternatives.
This distinction between true allergies and other conditions has vital implications. Accurately identifying whether someone has an actual allergy, intolerance, or another issue can considerably influence their treatment and overall quality of life.
Lactose intolerance can lead to discomfort after consuming dairy, but it isn’t an allergy, stemming instead from insufficient digesting capabilities due to a lack of the lactase enzyme.
There’s also the hereditary G6PD deficiency, sometimes inaccurately called a “fava bean allergy,” which is common among certain populations. This condition can cause red blood cell breakdown in individuals who consume fava beans or come into contact with specific substances.
In the past, there was a common misconception that those with G6PD deficiency couldn’t take the painkiller Optalgin. Nowadays, there’s no blanket prohibition against it, yet some still avoid it for fear of complications, potentially limiting their options for effective pain relief.
This deficiency isn’t an allergy but represents a different biological issue altogether.
It’s equally important to be open to revisiting established diagnoses. Medical classifications often stick with patients, persisting even when inaccurate.
Take, for instance, a Canadian woman who sought a second opinion in Israel after believing she had common variable immunodeficiency (CVID) for nearly thirty years.
Her life revolved around the fear of infections, leading her to rarely venture outside without a mask. When she came in for evaluation, the team didn’t just repeat tests— they thoroughly reassessed her entire case, consulting with multiple specialists.
It was only after a detailed review that they confidently pronounced her three-decade-old diagnosis incorrect—she never actually had CVID.
Yet, merely correcting the records didn’t erase the years of feeling vulnerable and defining her life through the lens of illness. Helping her rebuild trust in her health and outlook took ongoing empathy and time.
Overall, the revolution in allergy and immunology encompasses not just advancements in treatments but also a fundamental shift in thinking. By focusing on the mechanism behind diseases, physicians can address many allergic and immune disorders more effectively. For some patients, this new approach can even help reclaim a quality of life they thought was lost forever.
This progress fosters genuine hope. In recent years, immunology has reshaped various medical disciplines. Instead of suppressing the immune system indiscriminately, today’s biological therapies hone in on specific cells, proteins, or pathways involved in diseases.
Consequently, conditions that were once only manageable through symptom relief can now be controlled more effectively, sometimes leading to sustained remission.
While much about the immune system remains elusive and enigmatic, as scientists continue to unravel how immune cells interact and relate shared mechanisms across seemingly diverse conditions, new therapeutic options will emerge, bringing with them fresh hope.






